Zuosheng Li

Title: Zuosheng Li: Innovator in Antibody Development from Guangdong, China

Introduction

Zuosheng Li is a prominent inventor based in Guangdong, China, who has made significant contributions to the field of biotechnology. With two notable patents to his name, he has established himself as an influential figure in the development of innovative antibodies that have applications in medical science.

Latest Patents

Li's latest patents focus on the development of recombinant chicken IgY monoclonal antibodies and scFv antibodies targeting human thymidine kinase 1 (hTK1). The first patent details a preparation method and usage of these antibodies, which are raised in mammalian cells. The scFv antibody's light chain contains an amino acid sequence specified in SEQ ID NO: 1, while its heavy chain consists of the amino acid sequence in SEQ ID NO: 2.

The second patent highlights the expression of recombinant chicken IgY scFv antibodies and monoclonal antibodies produced in prokaryotic cells. This patent demonstrates the unique immunoreactivity, specificity, and sensitivity of the anti-hTK1 recombinant scFv antibodies, along with an efficient separation and purification process.

Career Highlights

Zuosheng Li is associated with Sino-Swed Tongkang Biotech (Shenzhen) Limited, where he employs his expertise in biochemistry and antibody engineering. His work continues to contribute to advancements in therapeutic applications, particularly in the detection and treatment of diseases linked to human thymidine kinase.

Collaborations

Throughout his career, Li has collaborated with notable colleagues such as Hu Chen and Huijun Li. These partnerships have allowed for enhanced research and development of effective antibodies, furthering their collective impact on the biotechnology industry.

Conclusion

Zuosheng Li's innovative work in the field of antibody development exemplifies the importance of scientific research and collaboration. His patents not only showcase his contributions to the field but also highlight advancements that could lead to significant improvements in medical diagnostics and therapies. As he continues to push the boundaries of biotechnology, his influence will be felt across various applications in health care.